Two indicted for smuggling counterfeit Ozempic to U.S.
Federal court filings say Swapnadip Roy and Vicky Ramancha were indicted in the Middle District of Florida in 2025 for allegedly smuggling and selling thousands of counterfeit Ozempic units into U.S. distribution channels from unauthorized manufacturers in China. The scheme ran from July 2023 through April 2024 and included fake packaging, inserts, labels and needles, the indictment says. Roy was extradited from Italy and made an initial court appearance, while Ramancha remains at large; both face up to 71 years if convicted. The case follows an FDA warning about counterfeit Ozempic and highlights cross-border enforcement and health risks.
Two people indicted for smuggling thousands of counterfeit Ozempic units.
Context
An indictment alleges a smuggling and counterfeiting scheme that ran from July 2023…
The full analysis
19 dimensions on this story — world impact, market read, and what happens next.
- Full ContextLocked
- Affected SectorsLocked
- Stock ImpactLocked
- Economic IndicatorLocked
- Investor RelevanceLocked
- Professional RelevanceLocked
- Watch PointsLocked
- Probability of ChangeLocked
- Debate PointsLocked
- Prerequisite KnowledgeLocked
- Follow-up QuestionsLocked
- Pros & ConsSome distributors: cheaper supply…Locked
Free account — 3 full analyses a day, no card.